On April 3, 2023 Genmab A/S (Nasdaq: GMAB) reported that its share buy-back program has been completed on March 31, 2023 (Press release, Genmab, APR 3, 2023, View Source [SID1234629745]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
On February 22, 2023, Genmab announced the initiation of a share buy-back program to honor our commitments under our Restricted Stock Unit program.
The share buy-back program was expected to be completed no later than March 31, 2023, and to comprise up to 220,000 shares.
The following transactions were executed under the program from March 27, 2023, to March 31, 2023:
No. of shares Average price (DKK) Total value (DKK)
Accumulated through last announcement 197,000 503,737,410
March 27, 2023 6,000 2,605.87 15,635,220
March 28, 2023 4,000 2,595.30 10,381,200
March 29,2023 5,000 2,572.86 12,864,300
March 30, 2023 5,000 2,581.26 12,906,300
March 31, 2023 3,000 2,578.87 7,736,610
Total 23,000 59,523,630
Accumulated under the program 220,000 563,261,040
Details of each transaction are included as an appendix to this announcement.
Genmab’s accumulated share buy-back from February 23, 2023, to March 31, 2023, amounts to 220,000 shares at a total cost of DKK 563.26 million. The announced share buy-back program has thus been completed.
Following these transactions, Genmab holds 763,416 shares as treasury shares, corresponding to 1.16% of the total share capital and voting rights.
The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 (‘MAR’) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the "Safe Harbour Regulation." Further details on the terms of the share buy-back program can be found in our company announcement no. 06 dated February 22, 2023.